Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 189-194

  Yu, Hong Nu ^a   Lee, Young Rae ^a   Noh, Eun Mi ^a   Lee, Kyung Sun ^a   Song, Eun Kyung ^a   Han, Myung Kwan ^a   Lee, Yong Chul ^a   Yim, Chang Yeol ^a   Park, Jinny ^b   Kim, Byeong Soo ^c   Lee, Sung Ho ^c   Lee, Seung Jin ^d   Kim, Jong Suk ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Gachon University   (South Korea)

^c Kongju National University   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

DMSO; Leukemic cell differentiation; MAPK; NF B; TNF

Indexed keywords

ALPHA INTERFERON; CD11 ANTIGEN; DIMETHYL SULFOXIDE; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA;

CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GRANULOCYTE PRECURSOR CELLS; HL-60 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42049115249     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0037-z     Document Type: Article

References (26)

1. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 1980;77:2936-40.
2. Collins SJ, Ruscetti FW, Gallagher RE, et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA. 1978;75:2458-62.
3. Ferrero D, Tarella C, Gallo E, et al. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation. Cancer Res. 1982;42:4421-6.
4. Fischkoff SA, Pollak A, Gleich GJ, et al. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med. 1984;160:179-96.
5. Huberman E, Callaham MF. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA. 1979;76:1293-7.
6. Hutt-Taylor SR, Harnish D, Richardson M, et al. Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60. Blood. 1988;71:209-15.
7. Mangelsdorf DJ, Koeffler HP, Donaldson CA, et al. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984;98:391-8.
8. Grant S, Bhalla K, Weinstein B, et al. Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation. Biochem Biophys Res Commun. 1985;130:379-88.
9. Leung KN, Mak NK, Fung MC, et al. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS). Immunology. 1994;81:65-72.
10. Llinares ME, Bermudez M, Fuster JL, et al. Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation. Pediatr Hematol Oncol. 2005;22:49-52.
11. Lee YR, Shim HJ, Yu HN, et al. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-kappaB activation in HL-60 cells. Leuk Res. 2005;29:401-5.
12. Schling P, Rudolph C, Heimerl S, et al. Expression of tumor necrosis factor alpha and its receptors during cellular differentiation. Cytokine. 2006;33:239-45.
13. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-71.
14. Regnier CH, Song HY, Gao X, et al. Identification and characterization of an IkappaB kinase. Cell. 1997;90:373-83.
15. Wang CY, Cusack JC Jr, Liu R, et al. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999;5:412-7.
16. Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta. 2000;1470:M55-62.
17. Keifer JA, Guttridge DC, Ashburner BP, et al. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J Biol Chem. 2001;276:22382-7.
18. Wen S, Stolarov J, Myers MP, et al. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA. 2001;98:4622-7.
19. Park BH, Park JW. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation. Exp Mol Med. 2001;33:64-8.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
21. Ishikura H, Hori K, Bloch A. Differential biologic effects resulting from bimodal binding of recombinant human tumor necrosis factor to myeloid leukemia cells. Blood. 1989;73:419-24.
22. Kumakura S, Ishikura H, Tsumura H, et al. C-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF alpha-treated HL-60 cells. Leuk Lymphoma. 1996;23:383-94.
23. Kumakura S, Ishikura H, Maniwa Y, et al. Activation of protein kinase C enhances TNF-alpha-induced differentiation by preventing apoptosis via rapid up-regulation of c-Myc protein expression in HL-60 cells. Leuk Lymphoma. 2003;44:497-503.
24. Zhang JX, Zhuang WJ, Poon KH, et al. Induction of HL-60 cell differentiation by the p38 mitogen-activated protein kinase inhibitor SB203580 is mediated through the extracellular signal-regulated kinase signaling pathway. Anticancer Drugs. 2003;14:31-8.
25. Yen A, Roberson MS, Varvayanis S, et al. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998;58:3163-72.
26. Lee YR, Yu HN, Noh EM, et al. TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells. Exp Mol Med. 2007;39:121-7.